Next 10 |
2024-04-25 08:13:17 ET Losers: Meta Platforms META -15% after Q1 earnings release . AGBA Group Holding Limited ( AGBA ) -13% . Marinemax HZO -11% after Q2 earnings release . Wimi Hologram Cloud ( WIMI ) -10% . International Business Mach...
2024-04-24 08:45:23 ET More on pre-market losers & stocks. ING: Still Too Cheap Despite Disappointing Results ING Groep NV (ING) Q4 2023 Earnings Call Transcript Palisade Bio stock rallies nearly 100% on colitis drug analysis Palisade Bio stock slides 8% ...
Silo Pharma (NASDAQ: SILO) is a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments. The company today announced positive data in the final validation report from the recent pharm...
Intranasal Delivery of SPC-15 shows rapid and effective drug exposure for PTSD Therapy SARASOTA, FL, April 23, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing...
2024-04-11 08:16:21 ET More on pre-market losers stock Grifols: Q4 Was Positive, Still Too Many Question Marks Altice USA: Recent Refinancing Buys Time But Challenges Remain Altice USA, Inc. (ATUS) Q4 2023 Earnings Call Transcript Altice slips as Wells Fargo ...
2024-04-10 10:02:03 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Well...
2024-04-10 08:21:32 ET More on Silo Pharma Seeking Alpha’s Quant Rating on Silo Pharma Historical earnings data for Silo Pharma Financial information for Silo Pharma Read the full article on Seeking Alpha For further details see: Silo Pharm...
SPC-14 shows cognitive and stress reduction benefits in preclinical models SARASOTA, FL, April 10, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing n...
Community Bancorp Inc Vermont (CMTV) is expected to report for Q4 2023 CISO Global, Inc (CISO) is expected to report for Q4 2023 TCTM Kids IT Education Inc. (TCTM) is expected to report for quarter end 2023-12-31 Generation Income Properties Inc. (GIPR) is expected to report for quart...
Silo Pharma (NASDAQ: SILO) is a developmental-stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments. The company today announced that it has exercised its option to license SPC-15, a prophylactic...
News, Short Squeeze, Breakout and More Instantly...
SILO Pharma Inc Company Name:
SILO Stock Symbol:
OTCMKTS Market:
Silo Pharma (NASDAQ: SILO) is a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments. The company today announced positive data in the final validation report from the recent pharm...
Intranasal Delivery of SPC-15 shows rapid and effective drug exposure for PTSD Therapy SARASOTA, FL, April 23, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing...
SPC-14 shows cognitive and stress reduction benefits in preclinical models SARASOTA, FL, April 10, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing n...